Docking and antibacterial activity of novel nontoxic 5-arylidenepyrimidine-triones as inhibitors of NDM-1 and MetAP-1

Future Med Chem. 2021 Jun;13(12):1041-1055. doi: 10.4155/fmc-2021-0020. Epub 2021 Apr 29.

Abstract

Background: Antibiotic resistance, which occurs through the action of metallo-β-lactamases (NDM-1), is a serious problem in the treatment of infectious diseases. Therefore, the discovery of new NDM-1 inhibitors and promising antibacterial agents as inhibitors of alternative targets (MetAP-1) is important. Method & results: In this study, a virtual library of 5-arylidene barbituric acids was created and molecular docking was performed for identification of novel possible inhibitors of NDM-1 and MetAP-1. Antibacterial activity (agar well-diffusion assay) and cytotoxicity (alamarBlue assay) of perspective compounds were evaluated. Pharmacokinetic profiles and molecular properties were predicted. Conclusion: We have identified possible novel inhibitors of NDM-1 and MetAP-1 with bacteriostatic activity, most of which are not cytotoxic and have potential excellent drug-likeness properties.

Keywords: 5-arylidene barbituric acids; 5-arylidenepyrimidine-2,4,6(1H,3H,5H)-triones; ADMET; New Delhi metallo-β-lactamase-1; antibacterial activity; cytotoxicity; methionine aminopeptidase-1; molecular docking.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aminopeptidases / antagonists & inhibitors
  • Aminopeptidases / metabolism
  • Animals
  • Anti-Bacterial Agents / chemical synthesis
  • Anti-Bacterial Agents / chemistry
  • Anti-Bacterial Agents / pharmacology*
  • Chlorocebus aethiops
  • Escherichia coli / drug effects
  • Humans
  • Microbial Sensitivity Tests
  • Molecular Docking Simulation*
  • Molecular Structure
  • Pyrimidines / chemical synthesis
  • Pyrimidines / chemistry
  • Pyrimidines / pharmacology*
  • Staphylococcus aureus / drug effects
  • Vero Cells
  • beta-Lactamase Inhibitors / chemical synthesis
  • beta-Lactamase Inhibitors / chemistry
  • beta-Lactamase Inhibitors / pharmacology*
  • beta-Lactamases / metabolism

Substances

  • Anti-Bacterial Agents
  • Pyrimidines
  • beta-Lactamase Inhibitors
  • Aminopeptidases
  • METAP1 protein, human
  • beta-Lactamases
  • beta-lactamase NDM-1
  • pyrimidine